Tech Company M&A Transactions
Miikana Acquisition
Operating out of Fremont, Miikana was bought by EntreMed. EntreMed said the transaction price was $21.2 million.
Transaction Overview
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
6519 Dumbarton Circle
Fremont, CA 94555
USA
Fremont, CA 94555
USA
Phone
Website
Email Address
Not Recorded
Overview
Miikana Therapeutics is a clinically driven biopharmaceutical company, discovering and developing targeted medicines for the treatment of cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 12/22/2005: Orexigen Therapeutics venture capital transaction
Next: 12/22/2005: ASOCS venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on funding rounds that are announced publicly. All VC database entries on this site are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs